What medications can patients with epilepsy take?
Generally speaking, the term "dianfengbing" refers to epilepsy. Medications available for epilepsy patients include Phenytoin Sodium Tablets, Carbamazepine Tablets, Lamotrigine Tablets, Levetiracetam Tablets, and Sodium Valproate Tablets. Detailed explanations are as follows:

1. Phenytoin Sodium Tablets
Phenytoin Sodium Tablets, as an antiepileptic and antiarrhythmic drug, can effectively increase sodium ion efflux and decrease sodium ion influx, thereby stabilizing the nerve cell membrane and reducing the spread of high-frequency discharges from the epileptic focus, achieving the effect of treating epilepsy.
2. Carbamazepine Tablets
Carbamazepine Tablets can effectively inhibit the generation and spread of abnormal high-frequency discharges and enhance the activity of central noradrenergic nerves, thus exerting anticonvulsant and antiepileptic effects. It is effective for both partial and generalized seizures.
3. Lamotrigine Tablets
Lamotrigine Tablets can effectively inhibit the release of pathological glutamate and reduce glutamate-induced action potentials, thereby treating epilepsy. It is mainly indicated for epilepsy treatment in patients over 12 years old.
4. Levetiracetam Tablets
Levetiracetam Tablets are antiepileptic drugs commonly used as adjunctive therapy for partial onset seizures in adults and children aged 4 years and older, effectively controlling the condition. It is primarily used for treating partial onset seizures in patients aged 4 years and older.
5. Sodium Valproate Tablets
Sodium Valproate Tablets can reduce neuronal excitability, thereby suppressing epileptic seizures. It is suitable for treating various types of epilepsy, particularly effective in the early stages of epileptic seizures. However, patients with abnormal liver function should not take this medication.
However, please note that all the above medications must be used under the guidance of a physician. Patients should not take medications or adjust dosages without authorization. During treatment, patients should regularly monitor plasma drug concentrations and seizure control, adjusting drug dosages or types according to clinical conditions and adverse reactions.